Lucy Xu

1 Patent

• US115987762023

  Biomarkers for Predicting and Assessing Responsiveness of Thyroid and Kidney Cancer Subjects to Lenvatinib Compounds

  Eisai R&D Management Co., Ltd.

  0 cites